Amino acids are now recognized to be widely present in mammals. Renal D-amino-acid oxidase (DAO) is associated with conversion of D-amino acids to the corresponding ␣-keto acids, but its contribution in vivo is poorly understood because the ␣-keto acids and/or L-amino acids formed are indistinguishable from endogenous compounds. First, we examined whether DAO is indispensable for conversion of D-amino ]leucine observed in rats suggested that kidney was the principal organ responsible for converting D-leucine to KIC. ␣-ketoisocaproic acid; kidney; nephrectomy ALL AMINO ACIDS, EXCEPT FOR GLYCINE, occur as optically active isomers. Amino acids used in protein synthesis are of the L-configuration, whereas D-amino acids rarely occur in proteins. Recent progress in chromatography on the separation of DL-amino acids reveals that significant amounts of several free D-amino acids are present in higher animals (5). A number of studies have indicated that D-amino acids play essential roles in several physiological functions (2, 9, 17). Because D-amino acids have also been found in foods and beverage drinks (3), it is considered that quite a few D-amino acids are taken into the body via these diets. Thus it has become important to understand how their levels are controlled.
␣-ketoisocaproic acid; kidney; nephrectomy ALL AMINO ACIDS, EXCEPT FOR GLYCINE, occur as optically active isomers. Amino acids used in protein synthesis are of the L-configuration, whereas D-amino acids rarely occur in proteins. Recent progress in chromatography on the separation of DL-amino acids reveals that significant amounts of several free D-amino acids are present in higher animals (5) . A number of studies have indicated that D-amino acids play essential roles in several physiological functions (2, 9, 17) . Because D-amino acids have also been found in foods and beverage drinks (3), it is considered that quite a few D-amino acids are taken into the body via these diets. Thus it has become important to understand how their levels are controlled.
D-Amino-acid oxidase (DAO; EC 1.4.3.3) is a flavoenzyme that catalyzes the oxidation of D-amino acids to the corresponding ␣-keto acids (15) . These ␣-keto acids are stereospecifically converted to their corresponding L-amino acids by transaminases. Almost all higher animals have DAO in their kidney, liver, and brain, although the mouse is an exception and does not have the enzyme in the liver (11) . Because DAO is present at the highest activity in the kidney compared with the other organs, injury to the kidney may cause accumulation of Damino acids. Increasing evidence that plasma levels of D-amino acids were significantly higher in patients with renal diseases than in healthy subjects (1, 18) suggests that renal DAO plays a prominent role in elimination of D-amino acids. However, little information is available on the contribution of renal DAO to the elimination of D-amino acids, because the ␣-keto acid and L-amino acid formed are indistinguishable from the endogenous ␣-keto acid and L-amino acid.
One of the unique advantages of the use of a stable isotopelabeled compound as a tracer is that an endogenous compound and its exogenously administered labeled analog are separately measurable by using gas chromatography-mass spectrometry (GC-MS). Our recent use of stable isotope-labeled D-leucine (D-[ 2 H 7 ]leucine) has proved a powerful methodology for examining the pharmacokinetic behavior of exogenously administered D-leucine and studying the conversion of D-leucine to the corresponding ␣-keto acid, ␣-ketoisocaproic acid (KIC), and L-leucine (6 -8, 16 ]leucine in our laboratory as described previously (7, 16 Ϫ mice lacking DAO activity were described before (10) . Male ddY/DAO Ϫ mice and normal ddY/DAO ϩ mice (7 wk old) were chosen for the experiment. Male Sprague-Dawley rats (7 wk old) were obtained from Tokyo Laboratory Animal Center (Tokyo, Japan). These animals were maintained in an air-conditioned room at 23 Ϯ 1°C and 55 Ϯ 5% humidity on a 12:12-h dark-light cycle. All animals were allowed free access to water and food (CE-2; Clea Japan, Tokyo, Japan).
Surgery. Rats (n ϭ 6) were anesthetized with pentobarbital sodium (50 mg/kg body wt ip), and the right kidneys were removed. At 3 days after the first surgery, the anterior and posterior apical segmental branches of the left kidney were removed under anesthesia. Rats (n ϭ 6) underwent sham operations with decapsulation of both kidneys at the same intervals as nephrectomy. After surgery, animals were allowed free access to water and food for 3 days.
Dose experiments. The ddY/DAO Ϫ and ddY/DAO ϩ mice (n ϭ 6 each) were fasted overnight. D-[ 2 H7]leucine was dissolved in saline (70 mol/ml) and administered (35 mol/kg body wt) into the tail vein. The mice were killed by cervical dislocation at 5 or 60 min after the administration, and a blood sample (300 l) was collected from the inferior vena cava. The blood was centrifuged to separate plasma at 3,000 rpm for 15 min. The plasma was stored at Ϫ20°C until analysis.
After an overnight fast, five-sixths (5/6)-nephrectomized and shamoperated rats (n ϭ 6 each) were anesthetized with pentobarbital sodium (50 mg/kg body wt ip). D-[ 2 H7]leucine (35 mol/kg body wt) was administered into the femoral vein. Blood samples (150 l) were obtained from the jugular vein 10 min before and 0.5, 1, 3, 5, 10, 15, 20, 30, 60, 90, 120, 180, 240, 300, and 360 min after the administration. The blood was centrifuged to separate plasma at 3,000 rpm for 10 min. The plasma was stored at Ϫ20°C until analysis.
Sample preparation for GC-MS-selected ion monitoring. ]KIC, D-leucine, L-leucine, and KIC were determined by the isotope dilution method as described previously (8) .
GC-MS-SIM. The GC-MS-SIM analysis was conducted on a Shimadzu (Kyoto, Japan) QP1000EX gas chromatograph-mass spectrometer equipped with a data processing system. The operating conditions were the same as those described in previous publications (6, 16) .
For leucine enantiomer analysis, the GC-MS conditions were as follows. The initial column temperature was set at 120°C. After the sample injection, temperature was maintained for 2 min, increased at 15°C/min to 190°C, and held at 190°C for 3 min. The mass spectrometer was operated in chemical ionization mode at 200 eV with isobutane as the reactant gas. SIM was performed on the quasimolecular ions of the (ϩ)-MTPA methyl ester (-OMe) derivatives of ]leucine spiked to rat plasma in the range of 0.5 to 50 nmol/ml were Ͻ5 and 4%, respectively. Similarly, the intra-and interday precision values for L-[ 2 H7]leucine were Ͻ9 and 5%, respectively. For KIC analysis, the GC-MS conditions were as follows. The initial column temperature was set at 120°C. After the sample injection, temperature was maintained for 2 min, increased at 30°C/min to 250°C, and held at 250°C for 2 min. The mass spectrometer was operated in electron impact ionization mode at 70 eV. SIM was performed on the molecular Fig. 1 with first-order rate constant. The differential equations for the model are as follows
where 
RESULTS

Metabolism of D-[ 2 H 7 ]leucine in mutant mice lacking DAO activity. After a bolus intravenous administration of D-[ 2 H 7 ]leucine to mutant ddY/DAO
Ϫ mice and normal ddY/ DAO ϩ mice, the plasma concentrations of the labeled and nonlabeled leucine enantiomers and KIC were determined by GC-MS-SIM (Figs. 2 and 3 ). As shown in Fig. 4 (Figs. 2-4 ). No detectable amounts of endogenous D-leucine were observed in the plasma from ddY/DAO ϩ mice, whereas considerable amounts of endogenous D-leucine were found in ddY/ DAO Ϫ mice, which were ϳ5% of total endogenous leucine (Fig. 5) . On the other hand, there were no differences in endogenous KIC and L-leucine concentrations between ddY/ DAO ϩ and ddY/DAO Ϫ mice (Fig. 5) 
The appearance of L-[ 2 H 7 ]leucine into the plasma was also rapid in both rats (Fig. 6C) . In the plasma at 1 min after administration of D- (Fig. 7A) , and no detectable amounts of endogenous D-leucine were found. As shown in Fig. 7B , the plasma concentration of endogenous KIC in 5/6-nephrectomized rats was almost constant for 6 h. On the other hand, KIC in sham-operated rats tended to fall gradually, reaching the minimum value of 16.8 Ϯ 5.3 nmol/ml at 15 min after the administration, and then increased steadily, which was consistent with our previous study in normal rats (8) .
DISCUSSION
Mutant mice lacking DAO activity were found in the ddY strain and had been established as inbred strains through brother-sister mating (10, 12, 14) . The mutant ddY/DAO Ϫ mice have a missense mutation (G541A) in the DAO gene, which causes the loss of enzyme activity (20) . The ddY/DAO Ϫ mice, in contrast to normal ddY/DAO ϩ mice, could not utilize D-phenylalanine for growth in place of its L-isomer. However, both ddY/DAO Ϫ and ddY/DAO ϩ mice utilized phenylpyruvic acid, the corresponding ␣-keto acid, in place of L-phenylalanine for growth. From these nutritional experiments, Konno and Yasumura (13) Considerable amounts of endogenous D-leucine were detected in the plasma of ddY/DAO Ϫ mice, which was consistent with the report by Hamase et al. (4) . We have determined the amounts of D-leucine in the diet (CE-2) by use of GC-MS-SIM and found that a considerable amount of D-leucine (20.0 nmol/g) is present. To our knowledge, there is no literature that demonstrates the presence of the biosynthesis of D-leucine in higher animals. Thus dietary D-leucine might be one of the possible sources.
In the present study, we found that renal mass reduction by partial nephrectomy slowed down the elimination of ϩ k 31 ) . The value in sham-operated rats was estimated to be 0.77, which was almost consistent with the value in our previous study in normal rats (8) . On the other hand, the fraction in 5/6-nephrectomized rats was markedly decreased to 0.25 (32%), which resulted from the DAO activity in the remnant kidney and other organs such as liver and brain. The decrease of renal DAO contents by nephrectomy may compensate DAO activity by inducing DAO. Nagata et al. (19) observed that DAO was not inducible in adult mice even with a high dose of D-alanine. Thus, assuming that DAO in liver and brain was not induced by nephrectomy, the DAO activity in kidney (x) and that in the other organs (y) were estimated by the following two simultaneous equations: x ϩ y ϭ 0.77 and x/6 ϩ y ϭ 0.25, and were calculated to be 0.62 and 0.15, respectively. Namely, the ratio of conversion in kidney occupied ϳ80% of overall conversion. These results suggested that the kidney was the principal organ responsible for converting D-leucine to KIC in vivo.
In conclusion, the present study shows that renal DAO plays the principal role in the metabolism of D-leucine in vivo. Because urinary excretion may also play a role in the elimination of D-leucine, it is important to establish the quantitative roles of metabolism by DAO compared with urinary excretion in both intact and 5/6-nephrectomized rats. We are now in the process of extending this approach to elucidate the overall role of the kidney in the elimination of D-leucine.
